| 000 | 00973 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517151407.0 | ||
| 264 | 0 | _c20171108 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1879-114X | ||
| 024 | 7 |
_a10.1016/j.clinthera.2017.03.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYao, Xuefang | |
| 245 | 0 | 0 |
_aThe New Drug Conditional Approval Process in China: Challenges and Opportunities. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cMay 2017 |
||
| 300 |
_a1040-1051 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aGovernment Agencies |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aDing, Jinxi | |
| 700 | 1 | _aLiu, Yingfang | |
| 700 | 1 | _aLi, Penghui | |
| 773 | 0 |
_tClinical therapeutics _gvol. 39 _gno. 5 _gp. 1040-1051 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinthera.2017.03.016 _zAvailable from publisher's website |
| 999 |
_c27102529 _d27102529 |
||